Header Logo

Connection

RENE GONZALEZ to Neoplasms, Second Primary

Back to Details
This is a "connection" page, showing publications RENE GONZALEZ has written about Neoplasms, Second Primary.
RENE GONZALEZ
Connection Strength
0.183
Neoplasms, Second Primary
  1. Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma. Clin Cancer Res. 2023 04 03; 29(7):1209-1219.
    View in: PubMed
    Score: 0.183
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.